Noninfectious meningitis related to nusinersen: a pharmacovigilance analysis using the WHO database. (PubMed, Neuromuscul Disord) - Sep 12, 2026 - "Awareness of non-infectious meningitis as a potential adverse reaction associated with nusinersen can simplify diagnosis and contribute to timely treatment. The benefits of nusinersen in terms of improving motor function and survival in patients with SMA clearly outweigh the rare risks."
Adverse events • Journal • CNS Disorders • Genetic Disorders • Infectious Disease • Movement Disorders • Muscular Atrophy • Rare Diseases
|
|
Bettina Schreiner; Jerome Bonzon; Leonie Kriz; Veronika Kana
|